Dilution:
Western Blot 1:10000-1:20000, Simple Western 1:25, Chromatin Immunoprecipitation reported in scientific literature (PMID 28196964), Flow Cytometry, Immunohistochemistry 2.5-5.0 ug/ml, Immunocytochemistry/Immunofluorescence 1:200-1:500, Immunoprecipitation 1:10-1:500, Immunohistochemistry-Paraffin 2.5-5.0 ug/ml, Immunoblotting reported in multiple pieces of scientific literature, RNA Inhibition reported in scientific literature (PMID 27694619), Chromatin Immunoprecipitation (ChIP), Knockout Validated, KnockDown Validated
Classification:
Polyclonal
Research Discipline:
Breast Cancer, Cancer, DNA Double Strand Break Repair, DNA Repair, Epigenetics, Genes Sensitive to DNA Damaging Agents
Formulation:
PBS with 0.05% Sodium Azide
Gene Alias:
DKFZp762A223, FA4, FACD, FAD, FAD2, FA-D2, FADFAD2, FANCD, Fanconi anemia complementation group D2, Fanconi anemia group D2 protein, Fanconi anemia, complementation group D2, FLJ23826, FPN1, HFE4, IREG1, Protein FACD2, SLC11A3
Purification Method:
Affinity Purified
Applications:
Western Blot, ChIP Assay, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunoprecipitation
Target Species:
Human, Mouse, Rat, Avian, Canine, Kangaroo, Primate, Zebrafish
Gene Accession No.:
Q9BXW9
Immunogen:
This FANCD2 Antibody was developed against human FANCD2 fusion protein (N-terminal fragment). [Swiss-Prot #Q9BXW9]
Primary or Secondary:
Primary
Content And Storage:
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.